CTOs on the Move

Active Pharma

www.activepharma.net

 
Active Pharma is a Surrey, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

OneWorld

OneWorld provides quality affordable health care, and individuals are welcome with or without insurance, including Medicaid and Medicare. OneWorld operates 13 clinical locations in Omaha; including the clinics at the Historic Livestock Exchange Campus, OneWorld West, Northwest Omaha, Cass Family Medicine, OneWorld Bellevue, Crossroads to Health and Recovery at Community Alliance, two mobile dental clinics, four school-based health centers and the South Omaha Learning Community Centers. Established in 1970, OneWorld Community Health Centers, in partnership with the community, provides culturally respectful, quality health care with special attention to the underserved. OneWorld is a federally qualified health center (FQHC) and provides comprehensive primary health care, dental, mental health/ substance abuse services, and affordable medications.

Med ISP

Med ISP is a Memphis, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CatalystRx

CatalystRx is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Philadelphia, PA. To find more information about CatalystRx, please visit www.catalystrx.com

Anthem

Anthem, Inc., is a provider of health insurance in the United States.

RaNA Therapeutics

RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.